Clear cellular ovarian cancer is a rare subtype ... undifferentiated carcinoma and germ cell ovarian cancer. Image: Organoid or ‘live mini tumours’ of high grade serous ovarian cancer grown in ICR ...

Results from DENALI Part 1b show an Objective Response Rate (ORR) of ~35% in response-evaluable, heavily-pretreated patients with Cyclin E1+ ...

SLFN11 is a BRCA independent biomarker for the response to platinum-based chemotherapy in high-grade serous ovarian cancer and clear cell ovarian carcinoma. Anticancer efficacy of KRASG12C ...

Learn more about whether Neogen Corporation or NovoCure Limited is a better investment based on AAII's A+ Investor grades, ...

A group of researchers in China have looked into the role of apolipoprotein B100 (ApoB100) in ovarian cancer following reports of excessive levels of ApoB100 inducing endoplasmic reticulum stress and ...

Ovarian cancer is caused by a harmful ... fallopian tubes and they include low grade and high grade tumor types. These cancers should be treated with surgery, radiation, targeted therapy, and ...

Learn more about whether AbbVie Inc. or Genmab A/S is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Section of Medicine, Royal Marsden Hospital and Institute of Cancer Research ... is not always clear. Ovarian serous adenocarcinomas have been reported to be bilateral in 57·5% of cases. 37 ...

Girentuximab is a monoclonal antibody that targets carbonic anhydrase IX, an enzyme highly expressed in clear cell renal carcinoma. Radiolabeled 89 Zr ... Most AEs were mild, with only 18 patients (6% ...

renal cell cancer, ovarian cancer, bladder cancer, head and neck cancer, and gastric cancer. While single agent CTLA-4 or PD-1 pathway blockade has demonstrated clear anti-tumor activity across ...